Apparatus and method for edman degradation using a microfluidic system
    21.
    发明申请
    Apparatus and method for edman degradation using a microfluidic system 审中-公开
    使用微流体系统进行埃德曼降解的装置和方法

    公开(公告)号:US20040175822A1

    公开(公告)日:2004-09-09

    申请号:US10740188

    申请日:2003-12-18

    IPC分类号: C12M001/34 G01N033/553

    摘要: An apparatus and method for Edman degradation using a microfluidic system to identify and characterize peptides is disclosed. A microfluidic device comprises an entrance channel through which a substantially purified polypeptide is accepted, a reaction channel engaging the entrance channel wherein the substantially purified polypeptide is digested, producing a digestion product, a reagent reservoir engaging the reaction channel, the reagent reservoir capable of delivering a reagent to the reaction channel, and an exit channel extending from the reaction channel, wherein the digestion product travels through the exit channel upon leaving the reaction channel. Protein digestion on the device comprises delivering a substantially purified polypeptide to a reaction channel, confining the polypeptide in the reaction channel, digesting the polypeptide in the reaction channel producing a digestion product, and removing the digestion product from the reaction channel, wherein the last two steps are repeated until the polypeptide is substantially digested.

    摘要翻译: 公开了使用微流体系统鉴定和表征肽的Edman降解的装置和方法。 微流体装置包括入口通道,基本上纯化的多肽被接受,入口通道的反应通道,其中基本上纯化的多肽被消化,产生消化产物,与反应通道接合的试剂储存器,能够递送的试剂储存器 反应通道的试剂和从反应通道延伸的出口通道,其中消除产物在离开反应通道时通过出口通道。 在装置上的蛋白质消化包括将基本上纯化的多肽递送至反应通道,将多肽限制在反应通道中,消化产生消化产物的反应通道中的多肽,以及从反应通道中除去消化产物,其中最后两个 重复步骤直到多肽被基本消化。

    Bearing life extender for conveyor type rollers
    22.
    发明申请
    Bearing life extender for conveyor type rollers 失效
    输送机类滚轮轴承寿命延长器

    公开(公告)号:US20040175067A1

    公开(公告)日:2004-09-09

    申请号:US10695551

    申请日:2003-10-28

    发明人: John L. Loth

    IPC分类号: F16C019/24

    CPC分类号: C23C2/003 F16C13/02 F27D3/026

    摘要: Rollers used on conveyors and inside the zinc-pot of a steel-sheet galvanizing line are usually driven by friction between the roller and the belt or sheet. To keep rollers from stalling, the bearing diameter is minimized. The allowable bending stress in the bearing shaft limits its length. Rollers operating in high temperature furnaces or in a hot zinc pot of a steel galvanizing line often have limited or non-existent bearing lubrication. In such cases, bearings of small diameter and limited length result in high contact pressure and short lifetime. Inside a zinc-pot, bearing life often does not exceed one week of operation. Most of these bearings are designed to have a stationary bearing housing with the roller shaft rotating inside. For small diameter rollers such shafts are an integral part of the roller. For cylindrical shell type rollers, short shafts are welded to plugs, which are then welded to each end of the roller. The herein disclosed nullBearing Life Extender For Conveyor Type Submerged Rollersnull utilizes bearings, which are smaller in diameter and longer, without an increase in shaft bending momentnull This is made possible by changing from a rotating cantilevered shaft to a stationary shaft strengthened to be substantially non-deflecting on either side of the bearings. Such a stationary shaft can be smaller in diameter to reduce bearing friction torque and stall problems. In addition such a shaft can have increased bearing contact area and assure bearing alignment, all of which contribute to increased bearing life.

    摘要翻译: 用于输送机的滚筒和钢板镀锌线的锌锅内部的辊通常由辊和带或片之间的摩擦驱动。 为了保持滚筒停止,轴承直径最小化。 轴承轴的允许弯曲应力限制其长度。 在高温炉或钢镀锌线的热锌锅中操作的辊通常具有有限的或不存在的轴承润滑。 在这种情况下,小直径和有限长度的轴承导致高接触压力和短的使用寿命。 在锌锅内,轴承寿命通常不超过一周的运行。 大多数这些轴承设计成具有固定的轴承壳体,辊轴在内部旋转。 对于小直径辊,这些轴是辊的组成部分。 对于圆柱形壳型辊,短轴焊接到插头上,然后将其焊接到辊的每一端。 本文所公开的“用于输送机型浸没辊的轴承寿命延长器”使用直径更小且更长的轴承,而不增加轴弯矩! 这可以通过从旋转的悬臂轴转变为固定轴来实现,该固定轴被加强以在轴承的任一侧基本上不偏转。 这样的固定轴的直径可以更小,以减少轴承摩擦扭矩和失速问题。 此外,这种轴可以具有增加的轴承接触面积并确保轴承对准,所有这些都有助于增加轴承寿命。

    Urea opthalmic ointment and solution
    28.
    发明授权
    Urea opthalmic ointment and solution 失效
    尿素眼药膏和溶液

    公开(公告)号:US5629344A

    公开(公告)日:1997-05-13

    申请号:US453201

    申请日:1995-05-30

    摘要: A topical ophthalmic preparation utilizing a urea and/or urea derivative or mixtures thereof as the principle active ingredient within a range of about 0.01% by weight to about 30% by weight and a method of using the same. When applied to a mammalian eye affected with an abnormal ophthalmological surface problem resulting in epithelial cell loss, keratinization, and/or scarring, the present invention will heal epithelial defects, soften keratin, decrease scarring, enhance hydration, and have anti-mucolytic activity. The present invention provides a method for treating ocular conditions such as dryness, noninfectious keratitis, corneal or conjunctival epithelial irregularities, ocular scarring and subjective irritations.

    摘要翻译: 使用尿素和/或尿素衍生物或其混合物作为主要活性成分的约0.01重量%至约30重量%范围内的局部眼用制剂及其使用方法。 当应用于导致上皮细胞丢失,角质化和/或瘢痕形成的异常眼科表面问题的哺乳动物眼睛时,本发明将治愈上皮缺陷,软化角蛋白,减少瘢痕形成,增强水合,并具有抗粘液分解活性。 本发明提供了治疗眼部疾病如干燥,非感染性角膜炎,角膜或结膜上皮不规则,眼瘢痕形成和主观刺激的方法。

    Urea ophthalmic ointment and solution
    29.
    发明授权
    Urea ophthalmic ointment and solution 失效
    尿素眼用软膏和溶液

    公开(公告)号:US5470881A

    公开(公告)日:1995-11-28

    申请号:US118265

    申请日:1993-09-09

    摘要: A topical ophthalmic preparation utilizing a urea and/or urea derivative or mixtures thereof as the principle active ingredient within a range of about 0.01% by weight to about 30% by weight and a method of using the same. When applied to a mammalian eye affected with an abnormal ophthalmological surface problem resulting in epithelial cell loss, keratinization, and/or scarring, the present invention will heal epithelial defects, soften keratin, decrease scarring, enhance hydration, and have anti-mucolytic activity. The present invention provides a method for treating ocular conditions such as dryness, noninfectious keratitis, corneal or conjunctival epithelial irregularities, ocular scarring and subjective irritations.

    摘要翻译: 使用尿素和/或尿素衍生物或其混合物作为主要活性成分的约0.01重量%至约30重量%范围内的局部眼用制剂及其使用方法。 当应用于导致上皮细胞丢失,角质化和/或瘢痕形成的异常眼科表面问题的哺乳动物眼睛时,本发明将治愈上皮缺陷,软化角蛋白,减少瘢痕形成,增强水合,并具有抗粘液分解活性。 本发明提供了治疗眼部疾病如干燥,非感染性角膜炎,角膜或结膜上皮不规则,眼瘢痕形成和主观刺激的方法。